{"AllianceGenome": "8000", "HGNC": "8000", "MIM": "602350", "_id": "4900", "_version": 1, "accession": {"genomic": ["AJ317956.2", "AP000866.4", "CH471065.1", "CP068267.2", "NC_000011.10", "NC_060935.1", "X99075.1", "X99076.1", "Y15058.1", "Y15059.1"], "protein": ["AAB49458.1", "AAH02835.1", "AAP35989.1", "CAA67532.1", "CAA67533.1", "CAA70867.1", "CAA75343.1", "CAC37631.1", "EAW67593.1", "EAW67594.1", "NP_001119653.1", "NP_006167.1", "Q92686.1"], "rna": ["BC002835.2", "BM923818.1", "BT007325.1", "DB474181.1", "NM_001126181.2", "NM_006176.3", "U89165.1", "Y09689.1"], "translation": [{"protein": "CAA70867.1", "rna": "Y09689.1"}, {"protein": "AAH02835.1", "rna": "BC002835.2"}, {"protein": "AAB49458.1", "rna": "U89165.1"}, {"protein": "NP_001119653.1", "rna": "NM_001126181.2"}, {"protein": "AAP35989.1", "rna": "BT007325.1"}, {"protein": "NP_006167.1", "rna": "NM_006176.3"}]}, "alias": ["RC3", "hng"], "ensembl": {"gene": "ENSG00000154146", "protein": ["ENSP00000284292", "ENSP00000399591"], "transcript": ["ENST00000284292", "ENST00000412681"], "translation": [{"protein": "ENSP00000284292", "rna": "ENST00000284292"}, {"protein": "ENSP00000399591", "rna": "ENST00000412681"}], "type_of_gene": "protein_coding"}, "entrezgene": "4900", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 2.02569869532, "exp_mis": 44.1022140643, "exp_syn": 27.8257904959, "lof_z": 1.40986376786367, "mis_z": 2.73266310415531, "mu_lof": 2.09955709927e-07, "mu_mis": 4.74890062371e-06, "mu_syn": 2.98674258458e-06, "n_lof": 0.0, "n_mis": 7.0, "n_syn": 10.0, "p_li": 0.536942023282865, "p_null": 0.0579739659109485, "p_rec": 0.405084010806187, "syn_z": 2.09495417199778}, "bp": 237, "cds_end": 124615620, "cds_start": 124609980, "n_exons": 2, "nonpsych": {"exp_lof": 1.80554006375, "exp_mis": 39.8888479428, "exp_syn": 25.1571168399, "lof_z": 1.31964017504967, "mis_z": 2.70640485297728, "mu_lof": 2.09955709927e-07, "mu_mis": 4.74890062371e-06, "mu_syn": 2.98674258458e-06, "n_lof": 0.0, "n_mis": 6.0, "n_syn": 9.0, "p_li": 0.546192678586479, "p_null": 0.0631521466409766, "p_rec": 0.390655174772545, "syn_z": 2.02813516071303}, "nontcga": {"exp_lof": 1.86092209319, "exp_mis": 40.571319149, "exp_syn": 25.5970116875, "lof_z": 1.34569095861885, "mis_z": 2.62584247663368, "mu_lof": 2.09955709927e-07, "mu_mis": 4.74890062371e-06, "mu_syn": 2.98674258458e-06, "n_lof": 0.0, "n_mis": 7.0, "n_syn": 9.0, "p_li": 0.530866921127559, "p_null": 0.0601861649531781, "p_rec": 0.408946913919263, "syn_z": 2.07710041655345}, "transcript": "ENST00000284292.6"}, "exons": [{"cdsend": 124745724, "cdsstart": 124740084, "chr": "11", "position": [[124739941, 124740099], [124745502, 124745729], [124745961, 124745982], [124746403, 124747210]], "strand": 1, "transcript": "NM_001126181", "txend": 124747210, "txstart": 124739941}, {"cdsend": 124745724, "cdsstart": 124740084, "chr": "11", "position": [[124739941, 124740099], [124745502, 124745729], [124745964, 124745982], [124746403, 124747210]], "strand": 1, "transcript": "NM_006176", "txend": 124747210, "txstart": 124739941}], "exons_hg19": [{"cdsend": 124615620, "cdsstart": 124609980, "chr": "11", "position": [[124609837, 124609995], [124615398, 124615625], [124615857, 124615878], [124616299, 124617106]], "strand": 1, "transcript": "NM_001126181", "txend": 124617106, "txstart": 124609837}, {"cdsend": 124615620, "cdsstart": 124609980, "chr": "11", "position": [[124609837, 124609995], [124615398, 124615625], [124615860, 124615878], [124616299, 124617106]], "strand": 1, "transcript": "NM_006176", "txend": 124617106, "txstart": 124609837}], "generif": [{"pubmed": 12808095, "text": "IL-2 deprivation raises the level of RC3 and other apoptotic factors, which induce apoptosis by increasing the intracellular Ca(2+) concentration"}, {"pubmed": 16677608, "text": "Nevertheless, by gel shift assays, Sp1 and Sp3 were not found to be responsible for the protein-DNA complexes formed by the GC-rich sequence."}, {"pubmed": 17140601, "text": "Genotype distribution showed association of the rs7113041 SNP with schizophrenia in males of Portuguese origin, which was confirmed by the analysis of the proband-parent triads."}, {"pubmed": 17140601, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18855024, "text": "Data suggest that BSX is essential for global cognitive function and that haplo-insufficiency may cause severe mental retardation, and that deletion of Neurogranin contributes to the auditory attention deficit observed in most 11q- patients."}, {"pubmed": 19571808, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20875798, "text": "Elevated cerebrospinal fluid neurogranin levels together with Alzheimer disease biomarkers may reflect synaptic degeneration."}, {"pubmed": 21037240, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21112188, "text": "No association between the schizophrenia associated NRGN variant rs12807809 and cognition could be detected in these samples."}, {"pubmed": 21538840, "text": "our study provides strong evidence that common exonic variation does not account for the genome-wide signi fi cant association between schizophrenia and variation at NRGN"}, {"pubmed": 21647148, "text": "Hippocampal activation diminished during the acquisition of contextual fear in healthy carriers of the genome-wide-supported risk variant for schizophrenia, rs12807809 in neurogranin."}, {"pubmed": 21799211, "text": "The influence of NRGN genotype on the neural correlates of memory encoding and retrieval is manifest in the cingulate cortex and is involved in hippocampal formation."}, {"pubmed": 22253779, "text": "The genome-wide associated genetic risk variant in the NRGN gene may be related to a small gray matter volume in the anterior cingulate cortex in the left hemisphere in patients with schizophrenia."}, {"pubmed": 22306195, "text": "This study demonistrated that multiple rare mutations in schizophrenia, and provides genetic clues that indicate the involvement of NRGN in this disorder."}, {"pubmed": 22461181, "text": "This study provides further evidence of the association of the NRGN gene with schizophrenia."}, {"pubmed": 22856365, "text": "single nucleotide polymorphism located upstream of the neurogranin (NRGN) gene has been identified as a risk variant for schizophrenia."}, {"pubmed": 23903071, "text": "Our results support an association between the NRGN gene and schizophrenia and a hypothesis that the NRGN gene may mediate the risk associated with schizophrenia via intellectual dysfunction."}, {"pubmed": 24098564, "text": "NRGN risk variants contribute to subtle changes in neural functioning and anatomy."}, {"pubmed": 24386483, "text": "These findings help to clarify underlying NRGN mediated pathophysiological mechanisms involving cortical-subcortical brain networks in schizophrenia."}, {"pubmed": 24713697, "text": "Data indicate that neurogranin makes contacts with both the N- and C-domains of calmodulin that functionally leads to altered calcium binding kinetics."}, {"pubmed": 25446004, "text": "neurogranin binds to alpha-synuclein in the human cortex, and this interaction decreases in Parkinson's disease along with the phosphorylation of neurogranin, a molecular process thought to be involved in learning and memory"}, {"pubmed": 26025774, "text": "This report provides evidence to support larger and controlled traumatic brain injury clinical studies for NRGN validation and prediction of outcomes."}, {"pubmed": 26366630, "text": "Within-person levels of NGRN increased in cognitively normal participants but not in patients with later stage mild cognitive impairment or Alzhiemer's disease; NGRN may reflect presymptomatic synaptic dysfunction or loss."}, {"pubmed": 26373605, "text": "Cerebrospinal fluid neurogranin was increased in patients with Alzheimer's dementia, progressive mild cognitive impairment (MCI) and stable MCI compared with controls, and in Alzheimer's dementia and progressive MCI compared with stable MCI."}, {"pubmed": 26698298, "text": "Neurogranin and YKL-40 are promising AD biomarkers, independent of and complementary to the established core Alzheimer's disease (AD) biomarkers, reflecting additional pathological changes in the course of AD"}, {"pubmed": 26826204, "text": "These results confirm an increase in CSF Ng concentration in patients with AD as previously reported and show that this is specific to AD and not seen in a range of other neurodegenerative diseases."}, {"pubmed": 26828755, "text": "Polymorphisms in NRGN are associated with schizophrenia, major depressive disorder and bipolar disorder in the Han Chinese population."}, {"pubmed": 27018940, "text": "The results of this results showed that increased CSF neurogranin levels in Alzheimer Disease."}, {"pubmed": 27604409, "text": "associations of neuromodulin and neurogranin to Alzheimer's disease"}, {"pubmed": 28389239, "text": "Study observed an association of rs12807809 with schizophrenia in a South Indian population. This study contributes toward the establishment of neurogranin as a susceptibility gene for schizophrenia South Indian Population."}, {"pubmed": 28449373, "text": "The dynamics of calmodulin interactions with neurogranin and Ca(2+) /CAMKII alpha proteins has been reported."}, {"pubmed": 28854881, "text": "Plasma neurogranin did not correlate with stroke severity."}, {"pubmed": 29429972, "text": "This study, cross-sectional analysis showed that high CSF Ng was significantly associated with lower memory scores in pooled participants with NC and MCI."}, {"pubmed": 29523639, "text": "Although the 3 assays target different epitopes on neurogranin and have different calibrators, the high correlations and the similar group differences suggest that the different forms of neurogranin in CSF carry similar diagnostic information"}, {"pubmed": 29700597, "text": "These data support that CSF Ng is increased specifically in Alzheimer disease, that high CSF Ng concentrations likely reflect synaptic dysfunction and that CSF Ng is associated with beta-amyloid plaque pathology."}, {"pubmed": 30733168, "text": "In first episode psychosis patients, levels of the synaptic marker CSF neurogranin appear unaltered."}, {"pubmed": 30953482, "text": "These findings are the first to suggest an association between rs12807809 and abnormal Papez circuit function in patients with SZ. This study also implicates NRGN variation and abnormal Papez circuit function in SZ pathophysiology."}, {"pubmed": 31234132, "text": "NRGN, S100B and GFAP levels are significantly increased in patients with structural lesions resulting from mild traumatic brain injuries."}, {"pubmed": 31837067, "text": "Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders."}, {"pubmed": 31861040, "text": "significant association between SNP rs12807809 and schizophrenia susceptibility in Caucasians but not Asians [meta-analysis]"}, {"pubmed": 32894885, "text": "Interrelations of Alzheimer s disease candidate biomarkers neurogranin, fatty acid-binding protein 3 and ferritin to neurodegeneration and neuroinflammation."}, {"pubmed": 32926148, "text": "Neurogranin as a Novel Biomarker in Alzheimer's Disease."}, {"pubmed": 33028119, "text": "The role of synaptic biomarkers in the spectrum of neurodegenerative diseases."}, {"pubmed": 33032807, "text": "Neurogranin, Encoded by the Schizophrenia Risk Gene NRGN, Bidirectionally Modulates Synaptic Plasticity via Calmodulin-Dependent Regulation of the Neuronal Phosphoproteome."}, {"pubmed": 33249594, "text": "Molecular forms of neurogranin in cerebrospinal fluid."}, {"pubmed": 33924468, "text": "Brain CHID1 Expression Correlates with NRGN and CALB1 in Healthy Subjects and AD Patients."}, {"pubmed": 35461266, "text": "Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer's disease."}, {"pubmed": 36481578, "text": "The diagnostic and prognostic value of serum neurogranin in acute ischemic stroke."}, {"pubmed": 38359746, "text": "Neurogranin expression regulates mitochondrial function and redox balance in endothelial cells."}], "genomic_pos": {"chr": "11", "end": 124747210, "ensemblgene": "ENSG00000154146", "start": 124739942, "strand": 1}, "genomic_pos_hg19": {"chr": "11", "end": 124617106, "start": 124609742, "strand": 1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0007165", "pubmed": 10075657, "qualifier": "involved_in", "term": "signal transduction"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007399", "pubmed": 10075657, "qualifier": "involved_in", "term": "nervous system development"}], "CC": {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, "MF": {"category": "MF", "evidence": "IEA", "id": "GO:0005516", "qualifier": "enables", "term": "calmodulin binding"}}, "homologene": {"genes": [[9544, 716063], [9598, 451638], [9606, 4900]], "id": 136802}, "interpro": {"desc": "IQ motif, EF-hand binding site", "id": "IPR000048", "short_desc": "IQ_motif_EF-hand-BS"}, "ipi": "IPI00022640", "map_location": "11q24.2", "name": "neurogranin", "other_names": ["calmodulin-binding protein", "neurogranin", "neurogranin (protein kinase C substrate, RC3)", "protein kinase C substrate"], "pathway": {"reactome": [{"id": "R-HSA-112314", "name": "Neurotransmitter receptors and postsynaptic signal transmission"}, {"id": "R-HSA-112314", "name": "Neurotransmitter receptors and postsynaptic signal transmission"}, {"id": "R-HSA-112315", "name": "Transmission across Chemical Synapses"}, {"id": "R-HSA-112315", "name": "Transmission across Chemical Synapses"}, {"id": "R-HSA-112316", "name": "Neuronal System"}, {"id": "R-HSA-112316", "name": "Neuronal System"}, {"id": "R-HSA-438064", "name": "Post NMDA receptor activation events"}, {"id": "R-HSA-438064", "name": "Post NMDA receptor activation events"}, {"id": "R-HSA-442755", "name": "Activation of NMDA receptors and postsynaptic events"}, {"id": "R-HSA-442755", "name": "Activation of NMDA receptors and postsynaptic events"}, {"id": "R-HSA-9620244", "name": "Long-term potentiation"}, {"id": "R-HSA-9620244", "name": "Long-term potentiation"}]}, "pfam": "PF00612", "pharmgkb": "PA31779", "pharos": {"target_id": 13997, "tdl": "Tbio"}, "prosite": "PS50096", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF253415", "relationship": "is"}, {"id": "GNF253416", "relationship": "is"}, {"id": "GNF253417", "relationship": "is"}, {"id": "GNF253418", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF160412", "relationship": "similar to"}, "GNF_hs-Origene": [{"id": "GNF030798", "relationship": "similar to"}, {"id": "GNF031352", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": {"id": "GNF086493", "relationship": "is"}, "GNF_hs-druggable_plasmid-shRNA": {"id": "GNF055240", "relationship": "is"}, "GNF_hs-druggable_siRNA": [{"id": "GNF070693", "relationship": "is"}, {"id": "GNF070694", "relationship": "is"}], "GNF_mm+hs-MGC": {"id": "GNF010513", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF285605", "relationship": "is"}, "NIBRI_hs-Secretome_pDEST": {"id": "GNF335187", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF095667", "relationship": "is"}, {"id": "GNF135324", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000011.10", "NC_060935.1"], "protein": ["NP_001119653.1", "NP_006167.1"], "rna": ["NM_001126181.2", "NM_006176.3"], "translation": [{"protein": "NP_001119653.1", "rna": "NM_001126181.2"}, {"protein": "NP_006167.1", "rna": "NM_006176.3"}]}, "reporter": {"HG-U133_Plus_2": "204081_at", "HG-U95Av2": "33925_at", "HTA-2_0": "TC11001143.hg.1", "HuEx-1_0": "3354227", "HuGene-1_1": "7944876", "HuGene-2_1": "16732891"}, "summary": "Neurogranin (NRGN) is the human homolog of the neuron-specific rat RC3/neurogranin gene. This gene encodes a postsynaptic protein kinase substrate that binds calmodulin in the absence of calcium. The NRGN gene contains four exons and three introns. The exons 1 and 2 encode the protein and exons 3 and 4 contain untranslated sequences. It is suggested that the NRGN is a direct target for thyroid hormone in human brain, and that control of expression of this gene could underlay many of the consequences of hypothyroidism on mental states during development as well as in adult subjects. [provided by RefSeq, Jul 2008].", "symbol": "NRGN", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1417847"}, "unigene": "Hs.524116", "uniprot": {"Swiss-Prot": "Q92686"}}